65,437 trials
Cardiac Transplant · Patent Ductus Arterious · Atrial Septal Defect
Primary: Changes in Hemodynamic Variables Recorded During Administration of Sevoflurane + Dexmedetomidine. — -0.14; -0.16; -0.21; 0.15 percentage of change from baseline — p=0.05
Recurrent Oral Cavity Adenoid Cystic Carcinoma · Recurrent Salivary Gland Carcinoma · Salivary Gland Adenoid Cystic Carcinoma
Primary: Confirmed Response Rate (Complete Response + Partial Response) According to RECIST Version 1.1 — 0 percentage of patients
Chronic HCV Infection
Primary: Percentage of Participants With Sustained Virologic Response (SVR) at 12 Weeks After Discontinuation of Therapy (SVR12), Treatment-naive, Noncirrhotic Participants…
Cervical Adenocarcinoma · Cervical Squamous Cell Carcinoma · Stage IB Cervical Cancer
Primary: Overall Survival (OS) — 11 participants still alive after 2 years — p=.42
Tissue and Organ Procurement · Alcohol Abstinence
Primary: Designated Organ Donor Status on Driver's License — 67; 38 participants
Coronary Disease · Ventricular Dysfunction, Left
Primary: Primary Composite Endpoint — 844; 832 participants — p=0.945
Lymphocytic Leukemia, Chronic
Primary: Percentage of Participants Achieving Confirmed Complete Response (CR) According to International Workshop on Chronic Lymphocytic Leukemia (IWCLL) 2008 Guidelines in the…
Liver Failure
Primary: Pharmacokinetics (Cmax and Cmin) of LCP-Tacro™ Compared to Prograf Early After Transplantations (Within the First 14 Days) in Adult de Novo Liver Transplant Recipients…
Coronary Artery Disease
Primary: Primary Composite Endpoint — 654; 611 participants — p=0.1969
Osteoporosis
Primary: Bone Mineral Density (BMD): Examine the Pattern and Effect of BMD Changes at Hip and Spine Measured by DXA Every 6 Months. — 0.85; 0.84; 0.91 percent change
Cardiac Arrest
Primary: Microvascular Flow Index (MFI) — 1.7; 1.1 units on a scale
Fibromyalgia
Primary: Change From Baseline to Week 15 in Mean Pain Diary Score — -1.60; -0.94 Units on a scale — p=0.121
Healthy Volunteers
Primary: Pharmacokinetics: Area Under the Concentration Versus Time Curve From Time Zero to Infinity [AUC(0-∞)] of Cephalexin Following a Single Dose — 36.256; 38.198…
Pigmented Villonodular Synovitis · Diffuse-type Giant Cell Tumor · Tenosynovial Giant Cell Tumor
Primary: Percentage of Participants With Progression Free Survival — 82 percentage of participants with PFS
Growth Hormone Deficiency
Primary: Change From Baseline in Height Standard Deviation Score (SDS) for Chronological Age (CA) at Month 36: Full Analysis Population — -2.91; 0.80 Standard Deviation Score…